Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 6 | $394,405 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 12 Feb 2024 20:22 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 12 Feb 2024 | Sale | 2,573 | 11.44 | 29,435 | D |
| 05 Feb 2024 19:12 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 02 Feb 2024 | Sale | 8,669 | 11.54 | 100,040 | D |
| 06 Oct 2023 19:18 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 04 Oct 2023 | Sale | 888 | 19.9102 | 17,680 | D |
| 06 Oct 2023 19:18 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 04 Oct 2023 | Sale | 4,594 | 19.4265 | 89,245 | D |
| 14 Feb 2023 19:10 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 14 Feb 2023 | Sale | 5,227 | 19.9753 | 104,411 | D |
| 14 Feb 2023 19:10 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 13 Feb 2023 | Sale | 2,624 | 20.4244 | 53,594 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)